Filter
282
Filtered Results: 282
Text search:
The
Polio
Global
Eradication
Initiative
Featured
Recommendations
17
New Publications
100
Language
Document type
No document type
181
Studies & Reports
35
Guidelines
31
Strategic & Response Plan
18
Manuals
7
Training Material
3
Fact sheets
3
Situation Updates
2
Resource Platforms
2
Countries / Regions
Nigeria
17
Global
16
India
11
Pakistan
10
Afghanistan
9
Sierra Leone
8
Africa
8
Liberia
7
Nepal
7
Congo, Democratic Republic of
6
Ethiopia
6
Uganda
6
Kenya
5
Namibia
5
Ukraine
5
Ghana
4
Philippines
4
Malawi
4
Latin America and the Carribbean
4
Somalia
3
South Sudan
3
Myanmar / Burma
3
Guinea
2
Senegal
2
Germany
2
Zambia
2
Syria
2
Indonesia
2
South Africa
2
Bangladesh
2
Chile
2
Middle East and North Africa
2
Haiti
1
Tanzania
1
Mozambique
1
Papua New Guinea
1
Central African Republic
1
Argentina
1
Peru
1
Eswatini/ Swaziland
1
Brazil
1
Colombia
1
Botswana
1
Bolivia
1
Angola
1
Lesotho
1
South–East Asia Region
1
Western and Central Europe
1
Venezuela
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
110
Clinical Guidelines
23
Women & Child Health
18
Public Health
14
Key Resources
4
Pharmacy & Technologies
4
Capacity Building
2
Toolboxes
Polio
65
COVID-19
23
Rapid Response
15
Conflict
9
Health Financing Toolbox
9
Global Health Education
8
Ebola
7
Disability
6
Caregiver
5
Refugee
4
HIV
4
NTDs
4
Pharmacy
3
Mental Health
2
Planetary Health
2
NCDs
2
Cholera
1
Natural Hazards
1
TB
1
Specific Hazards
1
AMR
1
On 16 February 2022, Malawi received confirmation of Wild Poliovirus Type 1 (WPV1) from an acute flaccid paralysis (AFP) case in Lilongwe.
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted ... link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the African Region the momentum towards achieving the 2030 SDG disease burden reduction targets (SDG targets 3.3, 3.4 and 3B) has stalled.
The COVID-19 pandemic was also a major threat to gains made, such as the eradication of polio in the region, declared in 2020; reduced numbers of new HIV infections in 2021 compared to 2010; and passing the 2020 milestone of the End TB Strategy, with a 22% reduction in new cases compared with 2015. However, the pandemic also disrupted essential health services in 92% of countries globally, 22.7 million children missed basic immunization, there was an increase in malaria and TB, and global deaths from TB rose for the first time since 2015.
Globalization and Health201612:63; DOI: 10.1186/s12992-016-0195-3
This ten year global plan for measles and rubella outlines the strategy that needs to be fully implemented to achieve the measles and rubella goals...
The power relations around global decisions which shape population health can be changed through new alliances and information flows. The Democrati...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers ... following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vaccines
Polio vaccination
Ebola (Sudan ebolavirus outbreak update)
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of ... WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tracks progress made with respect to disease burden reduction, elimination and eradication. It also highlights major emerging threats, opportunities and priorities in the fight against commu- nicable and non-communicable diseases in the region. It covers the period 2000-2022, but for some indicators, information is available only up to 2021.
The report shows the number of reported cases for malaria and vaccine preventable diseases (meningitis, measles, yellow fever, pertussis, diphtheria, tetanus, and polio); disease incidence due to HIV, tuberculosis and four major noncommunicable diseases (cardiovas- cular diseases, cancers, diabetes and chronic respira- tory diseases).
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration betw...
Pre-Publication draft version. Lat reviewed on 7th July 2017
The Executive Board at its 150th session noted an earlier version of this report.1 The present report provides an update on the implementation of <... Strategic Action Plan on Polio Transition (2018–2023)2 at the start of 2022, within the context of the coronavirus disease (COVID-19) pandemic.
The 12th Meeting of the Regional Certification Commission (RCC) for the Polio Endgame in ... Region of the Americas was conducted virtually due to the pandemic of COVID-19. The meeting was composed of 5 steps:
Step 1: An introductory meeting between RCC members and Secretariat
Step 2: Assessment of the annual and containment reports by the reviewers
Step 3: Observations and recommendations review
Step 4: A meeting between RCC Chair and the Secretariat to review the draft report and general recommendations of the meeting
Step 5: RCC meeting to review and approve the recommendations to each country and the final report and recommendations of the meeting
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
The report reflects on the trends, achievements and challenges in global health over the past de...
Financing Global Health 2016: Development Assistance, Public and Private Health Spending for the Pursuit of Universal Health Coverage presents a complete analysis of ... resources available for health in 184 countries, with a particular focus on development assistance for health (DAH). DAH was estimated to total $37.6 billion in 2016, up 0.1% from 2015. After a decade of rapid growth from 2000 to 2010 (up 11.4% annually), DAH grew at only 1.8% annually between 2010 and 2016. In low-income countries, where much DAH is targeted, DAH made up 34.6% of total health spending in 2016. In upper-middle- and high-income countries, which generally do not receive DAH, DAH accounted for only 0.5% of total health spending. The other 99.5% of health spending – government, prepaid private, and out-of-pocket spending – is the subject of our further analysis.
In an environment of stagnant donor funding and increasing private sector investment in low- and middle-income countries, actors in both the public and private sectors are increasingly interested in using blended finance approaches to catalyze new f...
